Trade Bayer ^BAYGn

Bayer CEO Share Purchase Highlights Confidence Despite Losses And Legal Risks

Bayer AG (BAYRY) Receives FDA Approval For Expanded MR Injector Application

10 Best German Stocks to Buy According to Analysts

Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma

Bayhep B (Bayer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Assessing Bayer (XTRA:BAYN) Valuation After A Strong One Year Share Price Recovery

BridgeBio Pharma Touts Attruby Uptake, Bayer's Europe Rollout and 2026-28 Pipeline Timelines at Leerink Conf

Bayer Stock Forecast | Q4 Net Loss, EBITDA Guidance | Capital.com

Building a gene editing lexicon: a model for rare and inherited disorders

IP Protection Key to Draw in Investment - The Economic Times

Assessing Bayer (XTRA:BAYN) Valuation After Weak Earnings And Cautious Guidance Trigger Share Price Slide

'India has intellectual power to be a leader in biomedical innovation,' says Bayer AG - The Economic Times

New Soybean Traits Aim to Protect Yield From SCN and Resistant Weeds

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

EPA chief met with Bayer CEO over supreme court fight, agency records show - Yahoo News Canada

Dr. Lior Shaltiel reports NUREXONE ANNOUNCES CORPORATE UPDAT

Musiala expected to sit out Leverkusen clash with load management prioritized - Yahoo Sports

Bayer takes its battle on pesticide liability to Kansas - Yahoo News Canada

Bayer takes its multi-front battle on pesticide liability to Kansas

Bayrab (Bayer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Bayer proposes Roundup settlement in US

Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study

BAYN: Roundup Settlement Progress Will Support Future Upside In Core Earnings

Report casts doubt on Kasper Hjulmand's future as Bayer Leverkusen coach - Yahoo Sports

Stephanie Seneff PhD Interview - Glyphosate & The Engineered Sick Care System

Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study

Health Matters: Alberta considers ending clock changes | Watch News Videos Online

Bayer provides update on Preceon Smart Corn at Commodity Classic

Missouri court grants preliminary approval for $7.3 billion nationwide Roundup settlement - Brownfield Ag News

Health Matters: New regulations targeting illegal drug chemicals, equipment | Watch News Videos Online

Bayer Remains Leader in Crop Sciences and Shows Burgeoning Innovation in Pharmaceuticals | Morningstar

Health Matters: GLP-1s could help curb substance use disorders | Watch News Videos Online

Thailand's hybrid seeds take root in Pampanga | Philstar.com

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Announces Earnings Results - Markets Daily

Bayer AG (OTC:BAYRY) Q4 2025 Earnings Call Transcript

Bayer's 2026 Profit Guidance Misses Market Expectations Amid Legal Struggles, ETPharma

Bayer Wins Court Nod for $7.25 Billion Roundup Settlement (3)

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Announces Earnings Results - Daily Political

Strategies to improve regional representation in heart failure randomized controlled clinical trials

Animal tranquilizers being mixed with fentanyl | Watch News Videos Online

Dow Jones Top Company Headlines at 3 PM ET: Ford Posts Lower U.S. Sales in February on Declines in Electric, Hybrid Vehicles | Bayer ... | Morningstar

Bayer's $7.25 billion Roundup settlement gets initial OK from Missouri judge - AOL

Dow Jones Top Company Headlines at 1 PM ET: Ford Posts Lower U.S. Sales in February on Declines in Electric, Hybrid Vehicles | Bayer ... | Morningstar

Dow Jones Top Company Headlines at 11 AM ET: Bayer Net Loss Widens on Weedkiller Litigation Charges | Abercrombie ... | Morningstar

Assessing Bayer (XTRA:BAYN) Valuation After New Prostate Cancer Data And Earnings Focus

Dow Jones Top Company Headlines at 9 AM ET: Bayer Net Loss Widens on Weedkiller Litigation Charges | Abercrombie ... | Morningstar

Dow Jones Top Company Headlines at 7 AM ET: Bayer Net Loss Widens on Weedkiller Litigation Charges | Adidas ... | Morningstar

Dow Jones Top Company Headlines at 5 AM ET: Adidas Targets Sales Growth, Market-Share Gains Through 2028 | Bayer ... | Morningstar

Bayer's profit guidance falls short of expectations - The Business Times

Bayer Net Loss Widens on Weedkiller Litigation Charges | Morningstar

Bayer Aktiengesellschaft Q4 Earnings Call Highlights - Daily Political

Health Matters: Estimated 3M Canadian currently taking GLP-1 drugs, Leger survey finds | Watch News Videos Online

Botanical and Plant-derived Drugs Global Research Report 2025: A $58.1 Billion Market by 2030, Driven by Plant Metabolites for Drug Discovery and Biotechnological Integration for Personalized Medicine

Donald Trump's executive order saves glyphosate production as Bayer weighs exit

In the clinic for March 2, 2026 | BioWorld

Health Matters: Advocacy groups call for gene-edited pork to be labelled | Watch News Videos Online

Shingles remains a costly, overlooked health risk: NIA report | Watch News Videos Online

Bayer ramps up hybrid seed output for Philippines, other markets | Philstar.com

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial

Glyphosate is in your bread… and the White House just gave its manufacturers legal immunity - NaturalNews.com

Bayer News | Markets Insider

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer | Morningstar

Crop protection takes center stage ahead of growing season - Brownfield Ag News

Deere Bayer Link Deepens Precision Ag Ecosystem And Valuation Debate

Deere Bayer Data Link Aims To Deepen Precision Farming Ecosystem

Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves

Is Bayer (XTRA:BAYN) Pricing In Legal Risks After An 84% One Year Share Price Surge?

Daybreak Feb. 26: Biofuels industry keeps eye on final RVO rule

Bayer Stock Forecast | $7.25bn Roundup Settlement Delay | Capital.com

Bangkok Post - Bayer inaugurates Khon Kaen Vegetable Seeds Production Centre as Asia Hub, strengthening regional and global supply

MediaPost Publications - Marketing Daily 02/26/2026

Lawyers for US cancer sufferers challenge Bayer's $7.25bn Roundup settlement deal

Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death

Bayer Sues J&J Over Claims For Prostate Cancer Drug 02/26/2026

Health Matters: Health advocates call for action against cervical cancer | Watch News Videos Online

MYQORZO® Approved for Adults with Symptomatic Obstructive HC

Bayer sues J&J over prostate cancer drug ad campaign - Ad Age

Fitness guru turned MAHA commentator Jillian Michaels rips Trump over his pesticides promotion

What Johnson & Johnson (JNJ)'s Prostate Cancer Drug Lawsuit Means For Shareholders

Assessing Bayer (XTRA:BAYN) Valuation After Mixed Annual Results And Strong Recent Share Returns

Bayer obtains label expansion for prostate cancer blockbuster Nubeqa in India

Bayer prostate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients

Bayer prostrate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients

Erleada Vs Nubeqa Prostate Cancer Treatment: Bayer Sues Johnson & Johnson, Says Misleading Erleada Ads Falsely Claim 51% Lower Death Risk vs. Nubeqa, ETBrandEquity

Bayer Sues Johnson & Johnson Over Alleged False Advertising of Prostate Cancer Drug Erleada vs Nubeqa, ETPharma

Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - Stock Observer

Health Matters: Ontario family health teams struggle with lack of competitive funding | Watch News Videos Online

Mr. Brent Willis reports VOYAGEUR PHARMACEUTICALS ANNOUNCES

Bayer sues Johnson & Johnson over marketing of prostate cancer drug

Bayer Alleges J&J's Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA | Morningstar

(via TheNewswire) Calgary, Alberta, Canada - TheNewswire -

BAYN: Roundup Settlement Progress Will Unlock Future Equity Upside

Bayer identifies SOS1 inhibitors for cancer | BioWorld

Health Matters: Conservatives plan motion to review health benefits for asylum seekers | Watch News Videos Online

Bayer Crop Science gets HIP with next-gen weed researchers | Campaspe News

Helping win the numbers game in cropping | Riverine Herald

Trump Invokes Defense Act For Monsanto Chemicals: Bayer, Agribusiness ETFs In Focus On New Critical Mineral Status For Phosphorus